A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter, Multiple Dose Study for the Induction and Maintenance of Clinical Response and Remission with MLN0002 in Patients with Moderate to Severe Ulcerative Colitis

  • De Villiers, Willem (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date11/21/08 → 6/30/13